103 related articles for article (PubMed ID: 29436682)
1. Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma.
Gao S; Shi Z; Li X; Li W; Wang Y; Liu Z; Jiang J
Oncol Rep; 2018 Apr; 39(4):1919-1929. PubMed ID: 29436682
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
3. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.
Li X; Chen YT; Hu P; Huang WC
Mol Cancer Ther; 2014 Apr; 13(4):855-66. PubMed ID: 24493696
[TBL] [Abstract][Full Text] [Related]
4. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
5. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro.
Wang Q; Hu R; Li W; Tai Y; Gu W; Das BC; Yang F; Ji J; Wang C; Zhou J
Mol Cell Endocrinol; 2021 Mar; 523():111135. PubMed ID: 33359761
[TBL] [Abstract][Full Text] [Related]
6. Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division.
Gholkar AA; Cheung K; Williams KJ; Lo YC; Hamideh SA; Nnebe C; Khuu C; Bensinger SJ; Torres JZ
J Biol Chem; 2016 Aug; 291(33):17001-8. PubMed ID: 27378817
[TBL] [Abstract][Full Text] [Related]
7. Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation.
Siqingaowa ; Sekar S; Gopalakrishnan V; Taghibiglou C
Biochem Biophys Res Commun; 2017 Jun; 488(1):136-140. PubMed ID: 28483521
[TBL] [Abstract][Full Text] [Related]
8. Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer.
Qiu C; Dongol S; Lv QT; Gao X; Jiang J
Int J Gynecol Cancer; 2013 Nov; 23(9):1629-34. PubMed ID: 24105476
[TBL] [Abstract][Full Text] [Related]
9. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
Li LH; Zhang PR; Cai PY; Li ZC
Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351
[TBL] [Abstract][Full Text] [Related]
11. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
[TBL] [Abstract][Full Text] [Related]
12. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.
Kamisuki S; Mao Q; Abu-Elheiga L; Gu Z; Kugimiya A; Kwon Y; Shinohara T; Kawazoe Y; Sato S; Asakura K; Choo HY; Sakai J; Wakil SJ; Uesugi M
Chem Biol; 2009 Aug; 16(8):882-92. PubMed ID: 19716478
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice.
Van Krieken R; Marway M; Parthasarathy P; Mehta N; Ingram AJ; Gao B; Krepinsky JC
Endocrinology; 2018 Mar; 159(3):1479-1495. PubMed ID: 29420703
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells.
Du Q; Liu J; Zhang X; Zhang X; Zhu H; Wei M; Wang S
Braz J Med Biol Res; 2018; 51(4):e6803. PubMed ID: 29490000
[TBL] [Abstract][Full Text] [Related]
16. Induction of Apoptosis in Endometrial Cancer (Ishikawa) Cells by Pogostemon cablin Aqueous Extract (PCAE).
Tsai CC; Chang YH; Chang CC; Cheng YM; Ou YC; Chien CC; Hsu YC
Int J Mol Sci; 2015 Jun; 16(6):12424-35. PubMed ID: 26042464
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
Qiao Q; Li H
Biochem Biophys Res Commun; 2016 Sep; 478(2):507-12. PubMed ID: 27381864
[TBL] [Abstract][Full Text] [Related]
18. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.
Zhang J; Jiang Y; Zhao Y; Wang W; Xie Y; Wang H; Yang Y
Tumour Biol; 2017 Jul; 39(7):1010428317712444. PubMed ID: 28718377
[TBL] [Abstract][Full Text] [Related]
20. Site-1 protease, a novel metabolic target for glioblastoma.
Caruana BT; Skoric A; Brown AJ; Lutze-Mann LH
Biochem Biophys Res Commun; 2017 Aug; 490(3):760-766. PubMed ID: 28645614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
